Anavex Life Sciences
AVXL
AVXL
56 hedge funds and large institutions have $22.5M invested in Anavex Life Sciences in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
92% less call options, than puts
Call options by funds: $74K | Put options by funds: $912K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
56
Holding in Top 10
–
Calls
$74K
Puts
$912K
Top Buyers
| 1 | +$508K | |
| 2 | +$409K | |
| 3 | +$281K | |
| 4 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$275K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
+$202K |
Top Sellers
| 1 | -$137K | |
| 2 | -$122K | |
| 3 | -$78K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$74.8K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$49K |